B78.1
Cutaneous strongyloidiasis
Clinical Classification Guidelines
Medical Intelligence & Overview
Cutaneous strongyloidiasis is a skin infection resulting from thelarvae of the parasitic nematode Strongyloides stercoralis. This condition is part of a broader spectrum of strongyloidiasis infections, which can involve the gastrointestinal tract, lungs, and skin. The skin manifestations occur when the larvae penetrate the skin, often leading to localized dermatitis or dermatitis-like symptoms. While it is more common in tropical and subtropical regions, cases can occur in other areas with poor sanitation. Understanding this condition helps to recognize its symptoms early and seek appropriate medical evaluation and care.
Causes & Symptoms
Clinical Causes: Contact with soil contaminated with Strongyloides stercoralis larvae Walking barefoot or handling contaminated soil Inadequate sanitation and hygiene practices Immunosuppressed states which increase susceptibility
Key Symptoms: Red, itchy skin at the site of larval penetration Formation of small blisters or pustules Localized swelling or inflammation Possible sensation of crawling or tingling sensation in the affected area In some cases, multiple lesions may develop at different sites
Diagnostic & Treatment
Diagnosis Path: Diagnosis often involves a combination of clinical evaluation and laboratory tests. A healthcare provider may examine skin lesions and take skin scrapings or biopsies to identify larvae microscopically. Additionally, blood tests can help detect eosinophilia or specific antibodies indicative of strongyloidiasis. In some cases, stool examinations may be conducted to identify larvae or eggs, especially if gastrointestinal symptoms are present. Imaging studies are rarely needed but may be utilized to assess systemic involvement.
Treatment Protocols: Treatment typically involves antiparasitic medications such as ivermectin or albendazole, which are effective in eliminating the parasite. The healthcare provider will determine the appropriate medication and duration based on the severity of infection. Management of skin lesions may include topical therapies to soothe symptoms. Addressing underlying risk factors, such as improving sanitation and wearing protective footwear, is essential to prevent reinfection. Regular follow-up might be necessary to ensure complete eradication of the parasite and monitor for potential complications.
Clinical Advice & FAQs
Billing Guidance
Is B78.1 a billable ICD-10 code?
Yes, B78.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report B78.1?
Clinical documentation must specify the nature of Cutaneous strongyloidiasis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference